Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Volume  5 (2011)
Volume  4 (2010)
Volume  3 (2009)
Volume  2 (2008)
Volume  1 (2007)
Related articles

VOLUME 7 , ISSUE 4 ( October-December, 2013 ) > List of Articles

REVIEW ARTICLE

Noninvasive Prenatal Testing for Fetal Aneuploidy

Mónica Echevarria, Carmen Comas, Bernat Serra, MaAngeles Rodríguez

Keywords : Noninvasive prenatal testing,Cell-free fetal DNA,Down syndrome,First-trimester screening

Citation Information : Echevarria M, Comas C, Serra B, Rodríguez M. Noninvasive Prenatal Testing for Fetal Aneuploidy. Donald School J Ultrasound Obstet Gynecol 2013; 7 (4):443-452.

DOI: 10.5005/jp-journals-10009-1316

License: CC BY-NC 4.0

Published Online: 01-06-2014

Copyright Statement:  Copyright © 2013; The Author(s).


Abstract

How to cite this article

Gabriel CC, Echevarria M, Rodríguez M, Serra B. Noninvasive Prenatal Testing for Fetal Aneuploidy. Donald School J Ultrasound Obstet Gynecol 2013;7(4):443-452.

PDF Share
  1. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen 2003;10(2):56-104.
  2. First-trimester or second-trimester screening, or both, for Down'syndrome. N Engl J Med 2005 Nov;353(19):2001-2011.
  3. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007 Sep;110(3):687-694.
  4. Presence of fetal DNA in maternal plasma and serum. Lancet 1997 Aug;350(9076):485-487.
  5. Presence of fetal RNA in maternal plasma. Clin Chem 2000 Nov;46(11):1832-1834.
  6. Noninvasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 2011 Apr;16(2):88-93.
  7. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002 Jul;22(7):609-615.
  8. Analysis of fetal blood cells in the maternal circulation: challenges, ongoing efforts, and potential solutions. Stem Cells Dev 2004 Feb;13(1):93-99.
  9. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007 Jan;8(1):71-77.
  10. Non-invasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci US A 2008 Oct;105(42):266-271.
  11. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008 Dec;105(51):20458-20463.
  12. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011 Mar;204(3):205.e1-11.
  13. Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem 2011 Jan;57(1):92-101.
  14. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011 Nov;13(11):913-920.
  15. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6(7):e21791.
  16. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011 Jul;57(7):1042-1049.
  17. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012 Mar;14(3):296-305.
  18. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012 May;119(5):890-901.
  19. Maternal plasma DNA analysis with massively parallel sequencing by ligations for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010 Mar; 56(3):459-463.
  20. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet 2009 Oct;41(10):1061-1067.
  21. Substantial biases in ultra-short read data sets from high-throughput DNA sequencing. Nucleic Acid Res 2008 Sep;36(16):e105.
  22. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Ob Gyn 2012 Apr;206(4):322.e1-e5.
  23. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012 Nov;207(5):374.e1-e6.
  24. Noninvasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gyn 2012 Aug;207(2):137.e1-e8.
  25. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012 Jan;32(1):1-7.
  26. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012 Apr;206(4):319.e1-e9.
  27. Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targets massively parallel sequencing of maternal plasma DNA. PLoS One 2012;7(5):e38154.
  28. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012 Dec;32(13):1233-1241.
  29. Reliable concurrent calling of multiple genetic alleles and 24-chromosome ploidy without embryo freezing using Parental Support TM technology (PS). Fertil Steril 2008 Sep;90(Suppl 1):S23.
  30. Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod 2010 Apr;25(4):1066-1075.
  31. Smith's recognizable patters of human malformation. 6th ed. Philadelphia: Elsevier Health Sciences/Saunders; 2006. p 8-87.
  32. Genetics in obstetrics and gynecology. Philadelphia: Elsevier Health Sciences/Saunders; 2002. p323-344.
  33. Validation of targeted sequencing of single-nucleotide polymorphisms for noninvasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013 Jun; 33(6):575-579.
  34. A copy number variation morbidity map of developmental delay. Nat Genet 2011 Aug;43(9):838-846.
  35. A multicenter, prospective, masked comparison of chromosomal microarray with standard karyotyping for routine and high risk prenatal diagnosis. Am J Obstet Gyn 2012 Jan;206(1):S2.
  36. Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012. Hum Reprod Update 2013 Jul-Aug;19(4):318-329.
  37. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors. Prenat Diagn 2012 Dec;32(13):1-8.
  38. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012 Dec;120(6):1532-1534.
  39. Prenatal detection of Down Syndrome using massively parallel sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn 2012 Jan;32(1):1-2.
  40. Position Statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis, April 2013. Prenat Diagn 2013 Jul;33(7):622-629.
  41. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 2013 Jun;22(3):291-295.
  42. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013 May;15(5):395-398.
  43. Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection. J Med Ethics 2012 Oct;38(10):614-618.
  44. Maternal serum protein profile and immune response protein subunits as markers for noninvasive prenatal diagnosis of trisomy 21, 18, and 13. Prenat Diagn 2013 Mar;33(3):223-231.
  45. Noninvasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn 2013 May;33(5):409-415.
  46. Noninvasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 2013 Mar;26(4):434-437.
  47. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012 Aug;32(8):730-734.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.